RESUMEN
Disruption of intestinal microbial communities appears to underlie many human illnesses, but the mechanisms that promote this dysbiosis and its adverse consequences are poorly understood. In patients who received allogeneic hematopoietic cell transplantation (allo-HCT), we describe a high incidence of enterococcal expansion, which was associated with graft-versus-host disease (GVHD) and mortality. We found that Enterococcus also expands in the mouse gastrointestinal tract after allo-HCT and exacerbates disease severity in gnotobiotic models. Enterococcus growth is dependent on the disaccharide lactose, and dietary lactose depletion attenuates Enterococcus outgrowth and reduces the severity of GVHD in mice. Allo-HCT patients carrying lactose-nonabsorber genotypes showed compromised clearance of postantibiotic Enterococcus domination. We report lactose as a common nutrient that drives expansion of a commensal bacterium that exacerbates an intestinal and systemic inflammatory disease.
Asunto(s)
Enterococcus/crecimiento & desarrollo , Microbioma Gastrointestinal , Enfermedad Injerto contra Huésped/microbiología , Trasplante de Células Madre Hematopoyéticas , Lactosa/metabolismo , Anciano , Animales , Disbiosis , Enterococcus/genética , Enterococcus/metabolismo , Heces/microbiología , Femenino , Microbioma Gastrointestinal/genética , Humanos , Intestinos/microbiología , Masculino , Ratones , Microbiota , Persona de Mediana Edad , ARN Ribosómico 16S , Análisis de Secuencia de ARN , Trasplante HomólogoRESUMEN
REASONS FOR PERFORMING STUDY: Joint inflammation and septic arthritis are both potential complications of intra-articular injections of bone marrow-derived mesenchymal stem cells (BM-MSCs). Clinicians may prophylactically co-inject BM-MSCs admixed with either antimicrobials or hyaluronic acid; however, the effect of these agents on cultured BM-MSCs is unknown. OBJECTIVE: To determine the effects of therapeutic levels of gentamicin, amikacin and hyaluronic acid on cultured equine BM-MSCs in vitro. STUDY DESIGN: In vitro experimental study. METHODS: Equine BM-MSCs from 4 healthy mature horses were isolated. Cultured BM-MSCs from each donor were incubated with gentamicin (150 mg), amikacin (250 mg), hyaluronic acid (22 mg) or 1% penicillin/streptomycin (control) under sterile conditions. Mesenchymal stem cells viability, proliferation, mediator secretion and culture media pH were measured. RESULTS: Incubation of BM-MSCs with gentamicin resulted in >95% MSC death after 45 min, and incubation of BM-MSCs with amikacin resulted in >95% MSC death after 2 h. Incubation of BM-MSCs with hyaluronic acid or penicillin/streptomycin (control) for up to 6 h resulted in sustained BM-MSC viability of 80% and >93%, respectively. All additives resulted in decreased media pH in the first minute; however, the pH then remained constant over the 6 h incubation period. No significant differences in BM-MSC proliferation or mediator secretion between the penicillin/streptomycin (control) and cells treated with hyaluronic acid were observed. CONCLUSION: Therapeutic concentrations of aminoglycoside antimicrobials are toxic to cultured equine BM-MSCs. The effects of hyaluronic acid on cultured MSC viability, proliferation and mediator secretion are minimal. POTENTIAL RELEVANCE: Based on these findings, the mixing of aminoglycoside antimicrobials and cultured equine BM-MSCs prior to therapeutic use is not recommended.
Asunto(s)
Amicacina/farmacología , Gentamicinas/farmacología , Caballos , Ácido Hialurónico/farmacología , Macrófagos/efectos de los fármacos , Células Madre Mesenquimatosas/efectos de los fármacos , Amicacina/administración & dosificación , Animales , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Técnicas de Cultivo de Célula , Proliferación Celular , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Gentamicinas/administración & dosificación , Ácido Hialurónico/administración & dosificación , Concentración de Iones de Hidrógeno , Viscosuplementos/administración & dosificación , Viscosuplementos/farmacologíaAsunto(s)
Terapia de Inmunosupresión/métodos , Trasplante de Riñón/métodos , Prednisona/administración & dosificación , Suero Antilinfocítico/administración & dosificación , Azatioprina/administración & dosificación , Cadáver , Ciclosporinas/administración & dosificación , Complicaciones de la Diabetes , Supervivencia de Injerto , Humanos , Análisis de SupervivenciaRESUMEN
Renal function in a living related kidney donor was evaluated 27 years after unilateral nephrectomy. The patient was normotensive and had no significant proteinuria. Creatinine was 0.8 mg. per dl. and creatinine clearance was 88 ml. per minute per 1.73 m.2 or 152 per cent of the single kidney pre-nephrectomy value. Tubular function assessed by the ability to lower urinary pH in response to an acid load was normal. Biopsy of the transplanted kidney 18 years after donation was histologically normal. This case represents one of the longest followup evaluations of a living related donor reported to date and it argues against any adverse effects of organ donation on the function of the remaining kidney.